Top Markets
Coin of the day
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rang in Aktien #29206
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Aktienkurs
$2.77
Marktkapitalisierung
$22.40M
Veränderung (1 Tag)
-0.93%
Veränderung (1 Jahr)
-17.48%
Land
JP
Handel Kringle Pharma, Inc. (4884)

Kategorie

Kursverlauf für Kringle Pharma, Inc. (4884)
Höchster Schlusskurs: $2.62 am 2026-08-01

Niedrigster Schlusskurs: $12.59 am 2020-12-01
Kursverlauf der Aktie von Kringle Pharma, Inc. von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 8.04%
2025 -54.41%
2024 6.61%
2023 27.74%
2022 -30.15%
2021 -54.62%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.75 38.90%
US
$1.02K 55.96%
NL
$144.97 419.40%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH